GOLDMAN SACHS GROUP INC - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 40 filers reported holding ELOXX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$45,000
-49.4%
27,588
+40.7%
0.00%
Q3 2019$89,000
-43.7%
19,604
+23.5%
0.00%
Q2 2019$158,000
-32.8%
15,875
-21.1%
0.00%
Q1 2019$235,000
+23.0%
20,131
+26.9%
0.00%
Q4 2018$191,000
-68.9%
15,869
-56.0%
0.00%
Q3 2018$615,000
-47.2%
36,079
-47.1%
0.00%
Q2 2018$1,165,00068,2230.00%
Other shareholders

There were no reported owners of ELOXX PHARMACEUTICALS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of ELOXX PHARMACEUTICALS INC shareholders